AltrixBio is an early-stage company focused on advancing our lead platform: LuCI™ AJN 003, an oral drug that replicates the metabolic success of bariatric surgery in treated of Type 2 Diabetes.
Bristol-Myers Squibb
319 followers
Astellas Pharma
63 followers
Viatris
54 followers
NYU Langone Health
51 followers
Alnylam Pharmaceuticals
50 followers
Syneos Health
38 followers
Catalent
35 followers
Organon
29 followers
Parexel
21 followers
Otsuka Group
22 followers
Charlie Health
15 followers
PCI Pharma Services
14 followers